Related Experiment Videos
Tetronomycin, a novel polyether of unusual structure
The Journal of Antibiotics
|February 1, 1982
Summary
Tetronomycin, a novel polycyclic ionophore polyether from Streptomyces, was structurally characterized. This unique compound exhibits antibacterial activity against Gram-positive bacteria.
Area of Science:
- Natural Product Chemistry
- Organic Chemistry
- Microbiology
Background:
- Streptomyces species are a rich source of novel bioactive compounds.
- Polycyclic ionophore polyethers possess diverse biological activities.
- The structural elucidation of new natural products is crucial for drug discovery.
Purpose of the Study:
- To isolate and characterize a novel polycyclic ionophore polyether, tetronomycin, from Streptomyces sp. nov.
- To determine the complete structure, including absolute configuration, of tetronomycin.
- To investigate the antibacterial activity of tetronomycin.
Main Methods:
- Isolation of tetronomycin from Streptomyces sp. nov. culture.
- X-ray crystallographic analysis of the mono-O-acetyltetronomycin silver salt for structure determination.
- Nuclear Magnetic Resonance (NMR) spectroscopy (proton and carbon) for signal assignment and correlation.
- Assay of antibacterial activity against Gram-positive bacteria.
Main Results:
- Tetronomycin (C34H50O8) was isolated and identified as a novel polycyclic ionophore polyether.
- The crystal structure and absolute configuration were established via X-ray analysis.
- Tetronomycin uniquely features a tetronic acid moiety instead of a carboxylic acid function.
- Unique structural features include a trisubstituted cyclohexane ring and a distinctive silver salt conformation.
- Extensive NMR studies facilitated complete signal assignment.
- Tetronomycin demonstrated activity against Gram-positive bacteria.
Conclusions:
- Tetronomycin represents a new class of polyether natural products with a unique tetronic acid moiety.
- The detailed structural elucidation provides a foundation for understanding its biological activity.
- Tetronomycin's antibacterial properties suggest potential therapeutic applications.